Inventor
ROSENZWEIG NETA
IL20 patents
Patents
20 patentsUS10144778B2Dec 4, 2018
Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
YEDA RES & DEV24 citations98
US9856318B2Jan 2, 2018
Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
YEDA RES & DEV22 citations98
US9534052B2Jan 3, 2017
Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease
YEDA RES & DEV24 citations98
US9512225B2Dec 6, 2016
Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease
YEDA RES & DEV25 citations98
US9394365B1Jul 19, 2016
Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease
YEDA RES & DEV62 citations98
US9512227B2Dec 6, 2016
Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease
YEDA RES & DEV23 citations96
US10214585B2Feb 26, 2019
Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
YEDA RES & DEV14 citations94
US9982048B2May 29, 2018
Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease
YEDA RES & DEV12 citations92
US9982049B2May 29, 2018
Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease
YEDA RES & DEV12 citations92
US9982047B2May 29, 2018
Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease
YEDA RES & DEV12 citations92
US9982050B2May 29, 2018
Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease
YEDA RES & DEV12 citations92
US9982051B2May 29, 2018
Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
YEDA RES & DEV12 citations92
US11643464B2May 9, 2023
Reducing systemic regulatory T cell levels or activity for treatment of a retinal degeneration disorder
YEDA RES & DEV5 citations86
US10981989B2Apr 20, 2021
Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
YEDA RES & DEV5 citations84
US10961309B2Mar 30, 2021
Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
YEDA RES & DEV2 citations84
US10618963B2Apr 14, 2020
Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
YEDA RES & DEV10 citations84
US10519237B2Dec 31, 2019
Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
YEDA RES & DEV10 citations84
US11884727B2Jan 30, 2024
Reducing systemic regulatory T cell levels or activity for treatment of amyotrophic lateral sclerosis
YEDA RES & DEV1 citations73
US11884728B2Jan 30, 2024
Reducing systemic regulatory T cell levels or activity for treatment of amyotrophic lateral sclerosis
YEDA RES & DEV1 citations73
US11492405B2Nov 8, 2022
Reducing systemic regulatory t cell levels or activity for treatment of disease and injury of the CNS
YEDA RES & DEV4 citations73